Razieh Sangsari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Razieh Sangsari has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Kayvan Mirnia
Children’s Medical Hospital, Tehran University of Medical Science, Tehran, Iran
21 shared publications - Maryam Saeedi
Children’s Medical Center, Pediatric Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran
11 shared publications Maryam Saeedi
Children's Medical Center, Pediatrics Center of Excellence Tehran University of Medical Sciences Tehran Iran
10 shared publicationsKayvan Mirnia
Children's Medical Center, Pediatrics Center of Excellence Tehran University of Medical Sciences Tehran Iran
5 shared publicationsMaliheh Kadivar
Department of Pediatrics, Division of Neonatology, School of Medicine, Tehran University of Medical Sciences, Children’s Medical Center, Tehran, Iran
5 shared publicationsAshkan Talebi
Children’s Medical Center, Pediatric Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran
2 shared publications
Latest Publications
- Open Access
- 21 June 2026
- Published by Brieflands
- Vol. 36 (4) , e162644
The Effect of Breastfeeding Position on the Treatment of Infantile Colic in Infants
Background: Excessive crying in infants can be challenging for both parents and healthcare providers. Colic is defined as crying for more than 3 hours per day for more than 3 days per week. Although colic is generally benign and self-limiting, appropriate parental education, particularly regarding breastfeeding techniques, may be beneficial. Objectives: We hypothesized that the laid-back breastfeeding position would be more effective than the traditional cradle-hold position in reducing the frequency of infantile colic. Methods: This prospective interventional cohort study was conducted among 50 infants who visited the neonatal clinic of Children’s Medical Center Hospital in Tehran from 2021 to 2024. The sample size of 50 participants (25 per group) was calculated based on a power analysis to achieve 80% power at a 5% significance level, with an anticipated 15% dropout rate based on previous literature. All participants were examined by a neonatologist. The inclusion criteria were breastfed infants with infantile colic. The exclusion criteria were prematurity, underlying disorders, and probiotic use. Eligible participants were referred to a midwifery expert for training in breastfeeding positions. Mothers recorded daily colic frequency and breastfeeding position for 1 week, and the data were collected by a blinded pediatric resident. Infants were allocated to a case group of 25 infants whose mothers were trained in the laid-back breastfeeding position and a control group of 25 infants whose mothers were trained in the cradle-hold position. Colic frequency was recorded and compared between groups. To minimize confounding, infants with different demographic characteristics were analyzed separately, and infants with a gestational age of less than 35 weeks or underlying disorders were excluded. Data were analyzed using the independent t-test, chi-square test, and correlation analysis. Quantitative variables were analyzed using the independent t-test, and potential confounders were controlled through strict eligibility criteria. Results: The mean frequency of colic episodes before education was 5.80 days (± 1.32) in the case group and 5.96 days (± 1.17) in the control group. After training in the respective breastfeeding positions, the mean frequency of colic episodes decreased to 4.32 days (± 1.70) in the case group and to 5.60 days (± 1.00) in the control group. This difference was statistically significant (P = 0.003). Conclusions: The laid-back breastfeeding position appears to be more effective than the cradle-hold position in reducing the frequency of infantile colic. Further studies are needed to confirm the effectiveness of this position in managing colic in infants.
- 21 June 2026
- Published by Brieflands
- Vol. 36 (4) , e162644
Open AccessThe Effect of Breastfeeding Position on the Treatment of Infantile Colic in Infants
Background: Excessive crying in infants can be challenging for both parents and healthcare providers. Colic is defined as crying for more than 3 hours per day for more than 3 days per week. Although colic is generally benign and self-limiting, appropriate parental education, particularly regarding breastfeeding techniques, may be beneficial. Objectives: We hypothesized that the laid-back breastfeeding position would be more effective than the traditional cradle-hold position in reducing the frequency of infantile colic. Methods: This prospective interventional cohort study was conducted among 50 infants who visited the neonatal clinic of Children’s Medical Center Hospital in Tehran from 2021 to 2024. The sample size of 50 participants (25 per group) was calculated based on a power analysis to achieve 80% power at a 5% significance level, with an anticipated 15% dropout rate based on previous literature. All participants were examined by a neonatologist. The inclusion criteria were breastfed infants with infantile colic. The exclusion criteria were prematurity, underlying disorders, and probiotic use. Eligible participants were referred to a midwifery expert for training in breastfeeding positions. Mothers recorded daily colic frequency and breastfeeding position for 1 week, and the data were collected by a blinded pediatric resident. Infants were allocated to a case group of 25 infants whose mothers were trained in the laid-back breastfeeding position and a control group of 25 infants whose mothers were trained in the cradle-hold position. Colic frequency was recorded and compared between groups. To minimize confounding, infants with different demographic characteristics were analyzed separately, and infants with a gestational age of less than 35 weeks or underlying disorders were excluded. Data were analyzed using the independent t-test, chi-square test, and correlation analysis. Quantitative variables were analyzed using the independent t-test, and potential confounders were controlled through strict eligibility criteria. Results: The mean frequency of colic episodes before education was 5.80 days (± 1.32) in the case group and 5.96 days (± 1.17) in the control group. After training in the respective breastfeeding positions, the mean frequency of colic episodes decreased to 4.32 days (± 1.70) in the case group and to 5.60 days (± 1.00) in the control group. This difference was statistically significant (P = 0.003). Conclusions: The laid-back breastfeeding position appears to be more effective than the cradle-hold position in reducing the frequency of infantile colic. Further studies are needed to confirm the effectiveness of this position in managing colic in infants.
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Medicine
- Vol. 2026 (1) , 9545724
Intracellular Cobalamin Defect in Early Infancy: A Cause of Hypotonia and Cytopenias
Intracellular cobalamin metabolism defects (ICMDs) are rare but inherited disorders that disrupt the conversion of cobalamin into its active cofactors, methylcobalamin and adenosylcobalamin. We report a 40‐day‐old female infant with progressive hypotonia, poor feeding, hydrocephalus, and pancytopenia, whose metabolic profile demonstrated severe hyperhomocysteinemia, elevated urinary methylmalonic acid, and low methionine despite normal serum vitamin B12. Bone marrow evaluation revealed profound hypercellularity with megaloblastic changes and hypersegmented neutrophils. These findings suggested an intracellular cobalamin defect, most consistent with the cblC subtype. Molecular analysis confirmed a homozygous frameshift mutation in the MMACHC gene, establishing the diagnosis of methylmalonic aciduria and homocystinuria, cblC type. Treatment with hydroxocobalamin, betaine, and folinic acid led to stabilization of hematologic parameters and significant clinical and biochemical improvement; however, it is important to recognize that therapy is not curative, and long‐term neurodevelopmental outcomes may remain guarded, especially in early‐onset cases.
- 1 January 2026
- Published by Wiley in Case Reports in Medicine
- Vol. 2026 (1) , 9545724
Open AccessIntracellular Cobalamin Defect in Early Infancy: A Cause of Hypotonia and Cytopenias
Intracellular cobalamin metabolism defects (ICMDs) are rare but inherited disorders that disrupt the conversion of cobalamin into its active cofactors, methylcobalamin and adenosylcobalamin. We report a 40‐day‐old female infant with progressive hypotonia, poor feeding, hydrocephalus, and pancytopenia, whose metabolic profile demonstrated severe hyperhomocysteinemia, elevated urinary methylmalonic acid, and low methionine despite normal serum vitamin B12. Bone marrow evaluation revealed profound hypercellularity with megaloblastic changes and hypersegmented neutrophils. These findings suggested an intracellular cobalamin defect, most consistent with the cblC subtype. Molecular analysis confirmed a homozygous frameshift mutation in the MMACHC gene, establishing the diagnosis of methylmalonic aciduria and homocystinuria, cblC type. Treatment with hydroxocobalamin, betaine, and folinic acid led to stabilization of hematologic parameters and significant clinical and biochemical improvement; however, it is important to recognize that therapy is not curative, and long‐term neurodevelopmental outcomes may remain guarded, especially in early‐onset cases.
- Open Access
- 1 October 2025
- Published by Maad Rayan Publishing Company in International Journal of Infectious Diseases
- Vol. 28 (10) , 551-556
Necrotizing Enterocolitis in Term Neonates: A Retrospective Chart Review from Children’s Medical Center, Tehran (2020–2023)
Background: Necrotizing enterocolitis (NEC) is one of the most life-threatening conditions affecting neonates admitted to the neonatal intensive care unit (NICU). Prematurity and low birth weight are the most widely recognized risk factors. However, NEC can also occur in term neonates. This study investigated the incidence, clinical presentation, and underlying medical conditions associated with NEC in term neonates at a tertiary referral children’s hospital in Tehran, Iran. Methods: A retrospective review was conducted on term neonates diagnosed with NEC from 2020 to 2023. Data were collected on demographics, clinical presentation, laboratory findings, underlying medical conditions, treatment, and outcomes. Results: Of 975 term neonates admitted to the NICU during the study period, 33 were diagnosed with NEC, yielding an incidence of 3.38% (95% CI: 2.33–4.72). The mean birth weight was 3.15±0.57 kg, and NEC symptoms appeared at a mean age of 18.3±8.1 days. Abdominal distention was the most common initial symptom (78.8%). A history of herbal medication intake was reported significantly higher compared to non-NEC term neonates (P=0.02). Medical management was sufficient in 87.9% of cases, and no mortality was observed. The median hospital stay was 9 days (IQR: 7–13). Conclusion: This study highlights a notable incidence of NEC among term neonates in a tertiary Iranian NICU and identifies herbal medication intake as a potential risk factor. These findings underscore the importance of early recognition and culturally sensitive preventive strategies in term infants, especially in regions where herbal remedies are commonly used.
- 1 October 2025
- Published by Maad Rayan Publishing Company in International Journal of Infectious Diseases
- Vol. 28 (10) , 551-556
Open AccessNecrotizing Enterocolitis in Term Neonates: A Retrospective Chart Review from Children’s Medical Center, Tehran (2020–2023)
Background: Necrotizing enterocolitis (NEC) is one of the most life-threatening conditions affecting neonates admitted to the neonatal intensive care unit (NICU). Prematurity and low birth weight are the most widely recognized risk factors. However, NEC can also occur in term neonates. This study investigated the incidence, clinical presentation, and underlying medical conditions associated with NEC in term neonates at a tertiary referral children’s hospital in Tehran, Iran. Methods: A retrospective review was conducted on term neonates diagnosed with NEC from 2020 to 2023. Data were collected on demographics, clinical presentation, laboratory findings, underlying medical conditions, treatment, and outcomes. Results: Of 975 term neonates admitted to the NICU during the study period, 33 were diagnosed with NEC, yielding an incidence of 3.38% (95% CI: 2.33–4.72). The mean birth weight was 3.15±0.57 kg, and NEC symptoms appeared at a mean age of 18.3±8.1 days. Abdominal distention was the most common initial symptom (78.8%). A history of herbal medication intake was reported significantly higher compared to non-NEC term neonates (P=0.02). Medical management was sufficient in 87.9% of cases, and no mortality was observed. The median hospital stay was 9 days (IQR: 7–13). Conclusion: This study highlights a notable incidence of NEC among term neonates in a tertiary Iranian NICU and identifies herbal medication intake as a potential risk factor. These findings underscore the importance of early recognition and culturally sensitive preventive strategies in term infants, especially in regions where herbal remedies are commonly used.
- Open Access
- 4 September 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (9)
Neonatal Refractory Seizures and Hyperammonemia in a Neonate With ALDH7A1 Deficiency
Pyridoxine‐dependent epilepsy (PDE) is a rare, autosomal recessive neurometabolic disorder characterized by intractable seizures responsive to pyridoxine. We present the case of an 11‐day‐old female neonate with a history of refractory multifocal seizures beginning on day three of life, accompanied by hepatomegaly, metabolic acidosis, elevated serum ammonia and lactate, and abnormal liver function tests. Despite multiple antiepileptic and metabolic treatments, seizures persisted, and the infant developed progressive metabolic disturbances. Genetic analysis revealed a homozygous pathogenic variant in the ALDH7A1 gene, confirming the diagnosis of PDE. The patient's condition deteriorated despite intensive management, culminating in cardiorespiratory arrest and death. This case underscores the importance of early recognition of PDE, especially in consanguineous populations, and highlights the critical need for prompt pyridoxine therapy to prevent fatal outcomes.
- 4 September 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (9)
Open AccessNeonatal Refractory Seizures and Hyperammonemia in a Neonate With ALDH7A1 Deficiency
Pyridoxine‐dependent epilepsy (PDE) is a rare, autosomal recessive neurometabolic disorder characterized by intractable seizures responsive to pyridoxine. We present the case of an 11‐day‐old female neonate with a history of refractory multifocal seizures beginning on day three of life, accompanied by hepatomegaly, metabolic acidosis, elevated serum ammonia and lactate, and abnormal liver function tests. Despite multiple antiepileptic and metabolic treatments, seizures persisted, and the infant developed progressive metabolic disturbances. Genetic analysis revealed a homozygous pathogenic variant in the ALDH7A1 gene, confirming the diagnosis of PDE. The patient's condition deteriorated despite intensive management, culminating in cardiorespiratory arrest and death. This case underscores the importance of early recognition of PDE, especially in consanguineous populations, and highlights the critical need for prompt pyridoxine therapy to prevent fatal outcomes.
- Open Access
- 15 July 2025
- Published by Brieflands in Journal of Comprehensive Pediatrics
- Vol. 16 (3)
COVID-19 Negative Neonates Despite Having an Index Case Positive in Family
Background: COVID-19 is a novel virus, and research on its infectivity and pathogenesis in neonates is ongoing. Objectives: We aimed to introduce a population of neonates who displayed signs and symptoms of infection but tested negative for COVID-19 by PCR, despite having direct exposure to the virus within their families, as confirmed by PCR testing. Methods: We conducted an observational cross-sectional study in the NICU and neonatal ward of the Children's Medical Center Hospital in Tehran, Iran, between August 2020 and 2021. Results: We included a total of 11 neonates in this study. These neonates presented with symptoms of viral infection but had negative PCR results. The mean onset of symptoms in our patients was 2.73 days, with a minimum of 1 day and a maximum of 5 days. Discussion: The possibility of false negatives in PCR testing could be attributed to testing during the early stages of infection when the viral load is low. As parents are understandably worried about their baby's risk of COVID-19 infection, they bring their infants to the hospital promptly at the onset of symptoms. Therefore, additional and delayed tests may be required to improve the accuracy of detecting newborn infections. Conclusions: Despite the small sample size and lack of testing for other viruses, our findings highlight the importance of considering false-negative PCR results in neonates with COVID-19 exposure.
- 15 July 2025
- Published by Brieflands in Journal of Comprehensive Pediatrics
- Vol. 16 (3)
Open AccessCOVID-19 Negative Neonates Despite Having an Index Case Positive in Family
Background: COVID-19 is a novel virus, and research on its infectivity and pathogenesis in neonates is ongoing. Objectives: We aimed to introduce a population of neonates who displayed signs and symptoms of infection but tested negative for COVID-19 by PCR, despite having direct exposure to the virus within their families, as confirmed by PCR testing. Methods: We conducted an observational cross-sectional study in the NICU and neonatal ward of the Children's Medical Center Hospital in Tehran, Iran, between August 2020 and 2021. Results: We included a total of 11 neonates in this study. These neonates presented with symptoms of viral infection but had negative PCR results. The mean onset of symptoms in our patients was 2.73 days, with a minimum of 1 day and a maximum of 5 days. Discussion: The possibility of false negatives in PCR testing could be attributed to testing during the early stages of infection when the viral load is low. As parents are understandably worried about their baby's risk of COVID-19 infection, they bring their infants to the hospital promptly at the onset of symptoms. Therefore, additional and delayed tests may be required to improve the accuracy of detecting newborn infections. Conclusions: Despite the small sample size and lack of testing for other viruses, our findings highlight the importance of considering false-negative PCR results in neonates with COVID-19 exposure.
- Open Access
- 25 June 2025
- Published by Brieflands in Nephro-Urology Monthly
- Vol. 17 (3)
Practical Management of Neonatal Hypernatremic Dehydration: A Clinical Study
Background: Neonatal hypernatremic dehydration can lead to severe complications. The primary treatment for this condition is rehydration. However, varied treatment strategies depend on the specific hospital context. Objectives: This study investigated the practical management of hypernatremia in neonates with hypernatremic dehydration to simplify the treatment of these patients. Methods: We conducted a prospective observational cohort study enrolling neonates (≤ 28 days, gestational age ≥ 37 weeks) presenting with dehydration and serum sodium > 150 mEq/L at the neonatal intensive care unit (NICU) of Children's Medical Center from 2022 to 2024. A standardized intervention protocol was implemented, including a resuscitation phase with intravenous normal saline boluses and individualized maintenance fluid therapy. Neonates were stratified into three subgroups based on initial serum sodium concentrations (150 - 165, 166 - 175, and ≥ 176 mEq/L). The primary outcome was the rate of plasma sodium reduction, while secondary and tertiary outcomes included normalization timeframes, adverse events, and mortality. Results: In forty-three included neonates, analysis of variance (ANOVA) showed no statistically significant difference in the rate of sodium decline. Time to achieve serum sodium < 150 mEq/L varied: Group 1 (≤ 4 8 hours), group 2 (≤ 72 hours), and group 3 (≤ 6 days). Rehydration therapy was generally effective; the only complication was a seizure in one of the group 3 patients, who was discharged, and after 4 months of follow-up, he had normal development. Conclusions: Careful monitoring and individualized treatment are crucial for managing sodium levels and preventing adverse events in this vulnerable population. Further studies are warranted to refine rehydration strategies and improve outcomes in neonates with hypernatremia.
- 25 June 2025
- Published by Brieflands in Nephro-Urology Monthly
- Vol. 17 (3)
Open AccessPractical Management of Neonatal Hypernatremic Dehydration: A Clinical Study
Background: Neonatal hypernatremic dehydration can lead to severe complications. The primary treatment for this condition is rehydration. However, varied treatment strategies depend on the specific hospital context. Objectives: This study investigated the practical management of hypernatremia in neonates with hypernatremic dehydration to simplify the treatment of these patients. Methods: We conducted a prospective observational cohort study enrolling neonates (≤ 28 days, gestational age ≥ 37 weeks) presenting with dehydration and serum sodium > 150 mEq/L at the neonatal intensive care unit (NICU) of Children's Medical Center from 2022 to 2024. A standardized intervention protocol was implemented, including a resuscitation phase with intravenous normal saline boluses and individualized maintenance fluid therapy. Neonates were stratified into three subgroups based on initial serum sodium concentrations (150 - 165, 166 - 175, and ≥ 176 mEq/L). The primary outcome was the rate of plasma sodium reduction, while secondary and tertiary outcomes included normalization timeframes, adverse events, and mortality. Results: In forty-three included neonates, analysis of variance (ANOVA) showed no statistically significant difference in the rate of sodium decline. Time to achieve serum sodium < 150 mEq/L varied: Group 1 (≤ 4 8 hours), group 2 (≤ 72 hours), and group 3 (≤ 6 days). Rehydration therapy was generally effective; the only complication was a seizure in one of the group 3 patients, who was discharged, and after 4 months of follow-up, he had normal development. Conclusions: Careful monitoring and individualized treatment are crucial for managing sodium levels and preventing adverse events in this vulnerable population. Further studies are warranted to refine rehydration strategies and improve outcomes in neonates with hypernatremia.
- Open Access
- 18 January 2025
- Published by Brieflands in Journal of Reports in Pharmaceutical Sciences
- Vol. 12 (1)
The Prevalence of Factors Contributing to Drug-Related Complications in Neonates with Sepsis
Background: Newborns in the neonatal intensive care unit (NICU) are exposed to numerous medications during their hospital stay. The clinical variability of neonates makes them particularly vulnerable to drug-related problems (DRPs), leading to potential treatment inefficacy. Objectives: This study aimed to investigate the prevalence of DRPs and identify associated risk factors in neonates with sepsis in the NICU. Methods: This prospective observational research was conducted at a children's medical center in Iran from December 1, 2021, to March 1, 2022. Data were collected through daily physician orders and nursing reports, with DRPs classified according to Cipolle's standards. Logistic regression was utilized to determine risk factors for DRPs, with significance set at P < 0.05. Results and Conclusions: A total of 272 neonates with sepsis were included in the study, with mean birth weight and gestational age of 1781 ± 912 g and 35.4 ± 1.3 weeks, respectively. DRPs were observed in 57.5% of neonates (95% CI: 55.8 - 63.8%), with ineffective drugs (24.1%) and dosage issues (19.7% too low, 22.6% too high) being the primary causes. Antimicrobials accounted for the majority of DRPs (61.2%), with Gentamicin (21.5%) and Amikacin (17.3%) being the most commonly involved medications. Risk factors for DRPs included feeding intolerance and vomiting, with ineffective drug selection and inappropriate dosing impacting treatment efficacy.
- 18 January 2025
- Published by Brieflands in Journal of Reports in Pharmaceutical Sciences
- Vol. 12 (1)
Open AccessThe Prevalence of Factors Contributing to Drug-Related Complications in Neonates with Sepsis
Background: Newborns in the neonatal intensive care unit (NICU) are exposed to numerous medications during their hospital stay. The clinical variability of neonates makes them particularly vulnerable to drug-related problems (DRPs), leading to potential treatment inefficacy. Objectives: This study aimed to investigate the prevalence of DRPs and identify associated risk factors in neonates with sepsis in the NICU. Methods: This prospective observational research was conducted at a children's medical center in Iran from December 1, 2021, to March 1, 2022. Data were collected through daily physician orders and nursing reports, with DRPs classified according to Cipolle's standards. Logistic regression was utilized to determine risk factors for DRPs, with significance set at P < 0.05. Results and Conclusions: A total of 272 neonates with sepsis were included in the study, with mean birth weight and gestational age of 1781 ± 912 g and 35.4 ± 1.3 weeks, respectively. DRPs were observed in 57.5% of neonates (95% CI: 55.8 - 63.8%), with ineffective drugs (24.1%) and dosage issues (19.7% too low, 22.6% too high) being the primary causes. Antimicrobials accounted for the majority of DRPs (61.2%), with Gentamicin (21.5%) and Amikacin (17.3%) being the most commonly involved medications. Risk factors for DRPs included feeding intolerance and vomiting, with ineffective drug selection and inappropriate dosing impacting treatment efficacy.
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Pediatrics
- Vol. 2025 (1)
Inspissated Bile Syndrome and Crigler–Najjar Syndrome Type II: When Two Rare Conditions Converge
Background: Inspissated bile syndrome (IBS) is a rare neonatal condition characterized by thickened bile leading to cholestasis, while Crigler–Najjar syndrome type II (CNS‐II) is an autosomal recessive disorder resulting in unconjugated hyperbilirubinemia. Both conditions pose significant risks, particularly when they converge during pregnancy. Case Presentation: We report a unique case involving a 20 day‐old female neonate born to a mother with CNS‐II who discontinued phenobarbital treatment during pregnancy. The mother presented with elevated indirect bilirubin levels (total 32, and direct 0.4 mg/dL) and normal liver function test, while the neonate exhibited prolonged jaundice and cholestasis with direct hyperbilirubinemia (total 8, and direct 5.4 mg/dL) upon admission. Treatment included ursodeoxycholic acid for the neonate, leading to normalization of bilirubin levels. The neonate’s growth and neurological development remained normal at 6 months. Discussion: This case emphasizes the significant risks associated with untreated CNS‐II during pregnancy, which likely contributed to the neonate’s IBS. Existing literature highlights the importance of maternal management in preventing severe neonatal complications associated with hyperbilirubinemia. Conclusion: This case highlights the importance of timely intervention in managing maternal metabolic disorders during pregnancy to improve neonatal health. Further research is essential to develop optimal treatment strategies for such cases.
- 1 January 2025
- Published by Wiley in Case Reports in Pediatrics
- Vol. 2025 (1)
Open AccessInspissated Bile Syndrome and Crigler–Najjar Syndrome Type II: When Two Rare Conditions Converge
Background: Inspissated bile syndrome (IBS) is a rare neonatal condition characterized by thickened bile leading to cholestasis, while Crigler–Najjar syndrome type II (CNS‐II) is an autosomal recessive disorder resulting in unconjugated hyperbilirubinemia. Both conditions pose significant risks, particularly when they converge during pregnancy. Case Presentation: We report a unique case involving a 20 day‐old female neonate born to a mother with CNS‐II who discontinued phenobarbital treatment during pregnancy. The mother presented with elevated indirect bilirubin levels (total 32, and direct 0.4 mg/dL) and normal liver function test, while the neonate exhibited prolonged jaundice and cholestasis with direct hyperbilirubinemia (total 8, and direct 5.4 mg/dL) upon admission. Treatment included ursodeoxycholic acid for the neonate, leading to normalization of bilirubin levels. The neonate’s growth and neurological development remained normal at 6 months. Discussion: This case emphasizes the significant risks associated with untreated CNS‐II during pregnancy, which likely contributed to the neonate’s IBS. Existing literature highlights the importance of maternal management in preventing severe neonatal complications associated with hyperbilirubinemia. Conclusion: This case highlights the importance of timely intervention in managing maternal metabolic disorders during pregnancy to improve neonatal health. Further research is essential to develop optimal treatment strategies for such cases.
- Open Access
- 28 December 2024
- Published by Brieflands in Nephro-Urology Monthly
- Vol. 17 (1)
Arginine Levels in Neonatal Hydronephrosis
Background: Fetal hydronephrosis (HN) is a prevalent condition detected in prenatal ultrasounds, affecting 1-5% of pregnancies. While mild cases often resolve without intervention, severe cases frequently require surgical treatment. Objectives: This study investigates the association between L-arginine levels and the severity of neonatal HN, as prior research has indicated L-arginine’s crucial role in kidney function. Methods: A prospective case-control study was conducted at the Children's Medical Center in Tehran from October 2021 to October 2023. Neonates with HN (n = 24) were compared with healthy control neonates (n = 24). Arginine levels in plasma and urine were measured using LC-MS/MS. Statistical analyses included Pearson correlation coefficients and receiver operating characteristic (ROC) curves to assess the need for surgical intervention. Results: Urine arginine levels were significantly lower in the HN group compared to the controls (P = 0.03), while plasma arginine levels showed no significant difference (P = 0.82). A significant positive correlation was found between urine arginine levels in the HN and control groups [r (24) = 0.44, P < 0.05], but no significant correlations with kidney measurements or clinical outcomes were observed. Thirteen patients (54.2%) required surgery, with ROC analysis indicating low sensitivity (AUC = 0.53, P = 0.7). Conclusions: Our findings suggest that urine arginine levels may be lower in neonates with HN, indicating a potential link between arginine and kidney function. However, further research is needed to validate these findings and explore the utility of arginine as a cost-effective biomarker for the early detection of kidney abnormalities in pediatric nephrology.
- 28 December 2024
- Published by Brieflands in Nephro-Urology Monthly
- Vol. 17 (1)
Open AccessArginine Levels in Neonatal Hydronephrosis
Background: Fetal hydronephrosis (HN) is a prevalent condition detected in prenatal ultrasounds, affecting 1-5% of pregnancies. While mild cases often resolve without intervention, severe cases frequently require surgical treatment. Objectives: This study investigates the association between L-arginine levels and the severity of neonatal HN, as prior research has indicated L-arginine’s crucial role in kidney function. Methods: A prospective case-control study was conducted at the Children's Medical Center in Tehran from October 2021 to October 2023. Neonates with HN (n = 24) were compared with healthy control neonates (n = 24). Arginine levels in plasma and urine were measured using LC-MS/MS. Statistical analyses included Pearson correlation coefficients and receiver operating characteristic (ROC) curves to assess the need for surgical intervention. Results: Urine arginine levels were significantly lower in the HN group compared to the controls (P = 0.03), while plasma arginine levels showed no significant difference (P = 0.82). A significant positive correlation was found between urine arginine levels in the HN and control groups [r (24) = 0.44, P < 0.05], but no significant correlations with kidney measurements or clinical outcomes were observed. Thirteen patients (54.2%) required surgery, with ROC analysis indicating low sensitivity (AUC = 0.53, P = 0.7). Conclusions: Our findings suggest that urine arginine levels may be lower in neonates with HN, indicating a potential link between arginine and kidney function. However, further research is needed to validate these findings and explore the utility of arginine as a cost-effective biomarker for the early detection of kidney abnormalities in pediatric nephrology.
- Open Access
- 26 December 2024
- Published by Brieflands in Iranian Journal of Pediatrics
- Vol. 35 (2)
Umbilical Cord Zinc Levels and Neonatal Anthropometric Measures: A Cross-Sectional Study in Iran
Background: Zinc (Zn) is one of the trace elements in the body that, despite its low level, plays important roles in molecular and cellular activities. A few investigations have assessed the correlations between cord blood Zn levels and neonatal anthropometric measures; however, the results are conflicting. Objectives: The purpose of the present study was to investigate the relationships between the Zn level in the umbilical cord blood and the birth weight, height, and head circumference of term newborns. Methods: A cross-sectional study was conducted on full-term newborns in Tehran, Iran, in 2021. Neonates’ Zn levels in umbilical cord blood were evaluated. Data related to perinatal and neonatal variables such as the number of pregnancies (gravida), birth height, weight, and head circumference were recorded, and their relationships with umbilical cord Zn levels were assessed. P-values < 0.05 were considered statistically significant. Results: One hundred mothers with a mean age of 30.792 ± 5.908 years and a parity of 2.693 ± 1.181 were included. Of all the newborns, 68% were boys, and 2% had low birth weight. The mean level of cord blood Zn was 107.703 ± 27.843 µg/dL. Evaluating the correlations between cord blood Zn levels and maternal and neonatal qualitative variables, data analysis showed no relationships between Zn levels and neonatal sex (P = 0.70), low birth weight (P = 0.87), and maternal underlying disease (P = 0.49). Data analysis regarding correlations between quantitative variables also showed no significant correlations between cord blood Zn levels and birth weight (P = 0.466), height (P = 0.466), and head circumference (P = 0.925). Conclusions: Although adequate Zn levels were observed in all neonates, these levels did not significantly influence neonatal anthropometric measures or immediate health indicators. Further studies with larger sample sizes are recommended to provide more comparative data, particularly in relation to long-term growth outcomes.
- 26 December 2024
- Published by Brieflands in Iranian Journal of Pediatrics
- Vol. 35 (2)
Open AccessUmbilical Cord Zinc Levels and Neonatal Anthropometric Measures: A Cross-Sectional Study in Iran
Background: Zinc (Zn) is one of the trace elements in the body that, despite its low level, plays important roles in molecular and cellular activities. A few investigations have assessed the correlations between cord blood Zn levels and neonatal anthropometric measures; however, the results are conflicting. Objectives: The purpose of the present study was to investigate the relationships between the Zn level in the umbilical cord blood and the birth weight, height, and head circumference of term newborns. Methods: A cross-sectional study was conducted on full-term newborns in Tehran, Iran, in 2021. Neonates’ Zn levels in umbilical cord blood were evaluated. Data related to perinatal and neonatal variables such as the number of pregnancies (gravida), birth height, weight, and head circumference were recorded, and their relationships with umbilical cord Zn levels were assessed. P-values < 0.05 were considered statistically significant. Results: One hundred mothers with a mean age of 30.792 ± 5.908 years and a parity of 2.693 ± 1.181 were included. Of all the newborns, 68% were boys, and 2% had low birth weight. The mean level of cord blood Zn was 107.703 ± 27.843 µg/dL. Evaluating the correlations between cord blood Zn levels and maternal and neonatal qualitative variables, data analysis showed no relationships between Zn levels and neonatal sex (P = 0.70), low birth weight (P = 0.87), and maternal underlying disease (P = 0.49). Data analysis regarding correlations between quantitative variables also showed no significant correlations between cord blood Zn levels and birth weight (P = 0.466), height (P = 0.466), and head circumference (P = 0.925). Conclusions: Although adequate Zn levels were observed in all neonates, these levels did not significantly influence neonatal anthropometric measures or immediate health indicators. Further studies with larger sample sizes are recommended to provide more comparative data, particularly in relation to long-term growth outcomes.